News & Press ReleasesFreidreich's Ataxia: The CHUM and its partners involved in an international study to better understand the disease and its progression over time
Uncoordinated movements, impaired speech caused by muscle weakness, diabetes and cardiomyopathy: Friedreich’s ataxia hits hard and early. This neurodegenerative orphan disease, for which no treatment exists, generally manifests between the ages of 5 and 15, initially affecting walking.
Occurring in 1 in 30,000 people, the disease is rare. To identify the best ways of monitoring its progression, a research network has been created. CHUM neurologist Antoine Duquette and his colleagues at the Centre de réadaptation Lucie-Bruneau are collaborating in an international study directed by Dr. David R. Lynch of the Children’s Hospital of Philadelphia.
Read the entire article HERE
Kyle Bryant was crowned king of his high school prom. Growing
up in Sacramento, California, he spent his childhood going to
school, snowboarding, playing baseball, and riding his bike
around the neighborhood with his buddies. A smart, athletic, popular
boy, Bryant’s future was bright. He knew early on that he was
destined to do something great with his life.
2020 (3)
Advocate